{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:20:12Z","timestamp":1762410012859,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.hrthm.2021.12.015","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T12:39:23Z","timestamp":1639658363000},"page":"361-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How to risk-stratify cardiac sarcoidosis patients with normal or near-normal ventricular function?"],"prefix":"10.1016","volume":"19","author":[{"given":"David","family":"Birnie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo B.","family":"Nery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2021.12.015_bib1","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.hrthm.2021.12.015_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2021.12.015_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.hrthm.2021.11.025","article-title":"Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis","volume":"19","author":"Bakker","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.12.015_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.12.015_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.12.015_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2021.12.015_bib7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"journal-title":"Erratum in Heart Rhythm","year":"2018","author":"Al-Khatib","key":"10.1016\/j.hrthm.2021.12.015_bib8"},{"key":"10.1016\/j.hrthm.2021.12.015_bib9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2021.12.015_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","article-title":"High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis","volume":"222","author":"Agoston-Coldea","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.12.015_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2021.12.015_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ehf2.12201","article-title":"Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis","volume":"5","author":"Smedema","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"21","key":"10.1016\/j.hrthm.2021.12.015_bib13","first-page":"01873","article-title":"The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: meta-analyses and systemic review","volume":"S0167-5273","author":"Adhaduk","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2021.12.015_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.12.015_bib15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.12.015_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006685","article-title":"Which patients with cardiac sarcoidosis should receive implantable cardioverter-defibrillators","volume":"11","author":"Birnie","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121024486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121024486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:55:13Z","timestamp":1761548113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527121024486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1547527121024486"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.12.015","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to risk-stratify cardiac sarcoidosis patients with normal or near-normal ventricular function?","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.11.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}